“呼吁解决在阿尔茨海默病和相关痴呆临床试验中西班牙裔/拉丁裔代表的结构性障碍:微观-中观-宏观视角”的勘误表

IF 4.9 Q1 CLINICAL NEUROLOGY

Alzheimer''s and Dementia: Translational Research and Clinical Interventions Pub Date : 2023-07-20 DOI:10.1002/trc2.12409

{"title":"“呼吁解决在阿尔茨海默病和相关痴呆临床试验中西班牙裔/拉丁裔代表的结构性障碍:微观-中观-宏观视角”的勘误表","authors":"","doi":"10.1002/trc2.12409","DOIUrl":null,"url":null,"abstract":"In the paper by Aranda, MP et al. (A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro-meso-macro perspective. Alzheimer's Dement. 2023; 9:e12389. https://doi.org/10.1002/trc2.12389), an error occurred in the preparation of the paper for publication, requiring the following corrections.In the initial publication of this article, the last author's name is misspelled. Elena Portacolonem should be Elena Portacolone.Additionally, under section 8.1, “specify goals for enrollment of underrepresented racial and ethnical participants” should be “specify goals for enrollment of underrepresented racial and ethnic participants”.The authors regret the errors.","PeriodicalId":53225,"journal":{"name":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","volume":null,"pages":null},"PeriodicalIF":4.9000,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/09/TRC2-9-e12409.PMC10357416.pdf","citationCount":"1","resultStr":"{\"title\":\"Erratum to “A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro-meso-macro perspective”\",\"authors\":\"\",\"doi\":\"10.1002/trc2.12409\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In the paper by Aranda, MP et al. (A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro-meso-macro perspective. Alzheimer's Dement. 2023; 9:e12389. https://doi.org/10.1002/trc2.12389), an error occurred in the preparation of the paper for publication, requiring the following corrections.In the initial publication of this article, the last author's name is misspelled. Elena Portacolonem should be Elena Portacolone.Additionally, under section 8.1, “specify goals for enrollment of underrepresented racial and ethnical participants” should be “specify goals for enrollment of underrepresented racial and ethnic participants”.The authors regret the errors.\",\"PeriodicalId\":53225,\"journal\":{\"name\":\"Alzheimer''s and Dementia: Translational Research and Clinical Interventions\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2023-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/09/TRC2-9-e12409.PMC10357416.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer''s and Dementia: Translational Research and Clinical Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/trc2.12409\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Translational Research and Clinical Interventions","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/trc2.12409","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 1

摘要

在Aranda, MP等人的论文中(呼吁解决西班牙裔/拉丁裔代表在阿尔茨海默病和相关痴呆临床试验中的结构性障碍:微观-中观-宏观视角)。老年痴呆症;2023;9: e12389。https://doi.org/10.1002/trc2.12389)，在准备发表的论文中出现了错误，需要进行以下更正。这篇文章最初发表时，最后一位作者的名字拼错了。埃琳娜·波塔科伦应该是埃琳娜·波塔科伦。此外，在第8.1节中，“指定招收代表性不足的种族和族裔参与者的目标”应该是“指定招收代表性不足的种族和族裔参与者的目标”。作者对这些错误表示遗憾。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Erratum to “A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro-meso-macro perspective”

In the paper by Aranda, MP et al. (A call to address structural barriers to Hispanic/Latino representation in clinical trials on Alzheimer's disease and related dementias: A micro-meso-macro perspective. Alzheimer's Dement. 2023; 9:e12389. https://doi.org/10.1002/trc2.12389), an error occurred in the preparation of the paper for publication, requiring the following corrections.

In the initial publication of this article, the last author's name is misspelled. Elena Portacolonem should be Elena Portacolone.

Additionally, under section 8.1, “specify goals for enrollment of underrepresented racial and ethnical participants” should be “specify goals for enrollment of underrepresented racial and ethnic participants”.

The authors regret the errors.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Alzheimer''s and Dementia: Translational Research and Clinical Interventions Medicine-Psychiatry and Mental Health

CiteScore

10.10

自引率

2.10%

发文量

134

审稿时长

10 weeks

期刊介绍： Alzheimer''s & Dementia: Translational Research & Clinical Interventions (TRCI) is a peer-reviewed, open access,journal from the Alzheimer''s Association®. The journal seeks to bridge the full scope of explorations between basic research on drug discovery and clinical studies, validating putative therapies for aging-related chronic brain conditions that affect cognition, motor functions, and other behavioral or clinical symptoms associated with all forms dementia and Alzheimer''s disease. The journal will publish findings from diverse domains of research and disciplines to accelerate the conversion of abstract facts into practical knowledge: specifically, to translate what is learned at the bench into bedside applications. The journal seeks to publish articles that go beyond a singular emphasis on either basic drug discovery research or clinical research. Rather, an important theme of articles will be the linkages between and among the various discrete steps in the complex continuum of therapy development. For rapid communication among a multidisciplinary research audience involving the range of therapeutic interventions, TRCI will consider only original contributions that include feature length research articles, systematic reviews, meta-analyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that would advance wide range of interventions to ameliorate symptoms or alter the progression of chronic neurocognitive disorders such as dementia and Alzheimer''s disease. The journal will publish on topics related to medicine, geriatrics, neuroscience, neurophysiology, neurology, psychiatry, clinical psychology, bioinformatics, pharmaco-genetics, regulatory issues, health economics, pharmacoeconomics, and public health policy as these apply to preclinical and clinical research on therapeutics.